Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Nicolas

Showing results (481-490 of 499) with videos related to

Pageof 50
Sort By:
Regulatory Peptides|November 5, 1998
NPY receptor subtypes involved in the contraction of the proximal colon of the ratM Félétou, M Rodriguez, P Beauverger, et al.
Frontiers in Oncology|August 1, 2020
High Expression of FAP in Colorectal Cancer Is Associated With Angiogenesis and Immunoregulation ProcessesMairene Coto-Llerena, Caner Ercan, Venkatesh Kancherla, et al.
Pancreas|September 14, 2017
Efficacy of Peptide Receptor Radionuclide Therapy in a United States-Based Cohort of Metastatic Neuroendocrine Tumor Patients: Single-Institution Retrospective AnalysisBryson W Katona, Giorgio A Roccaro, Michael C Soulen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 11, 2025
Targeted β<sup>-</sup>-Particle Plus Conversion and Auger-Electron Therapy with <sup>161</sup>Tb-Labeled Somatostatin Receptor Antagonist DOTA-LM3: A Phase 0 StudyJulia G Fricke, Frida Westerbergh, Lisa McDougall, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 5, 2024
First-in-human administration of [<sup>161</sup>Tb]Tb-SibuDAB and comparative dosimetry with standard [<sup>177</sup>Lu]Lu-PSMA-I&T as part of the PROGNOSTICS phase Ia studyAlin Chirindel, Guillaume P Nicolas, Frida Westerbergh, et al.
The Journal of Clinical Endocrinology and Metabolism|August 11, 2021
Metastatic Medullary Thyroid Cancer: The Role of 68Gallium-DOTA-Somatostatin Analogue PET/CT and Peptide Receptor Radionuclide TherapyAimee R Hayes, Alexander Crawford, Khulood Al Riyami, et al.
Nature Communications|June 24, 2017
January 2016 extensive summer melt in West Antarctica favoured by strong El NiñoJulien P Nicolas, Andrew M Vogelmann, Ryan C Scott, et al.
Scientific Reports|May 19, 2022
Adaptation of the gut pathobiont Enterococcus faecalis to deoxycholate and taurocholate bile acidsF Repoila, F Le Bohec, C Guérin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 26, 2024
Dosimetry and pharmacokinetics of [<sup>177</sup>Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumoursSeval Beykan Schürrle, Uta Eberlein, Catherine Ansquer, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2001
Fit genotypes and escape variants of subgroup III Neisseria meningitidis during three pandemics of epidemic meningitisP Zhu, A van der Ende, D Falush, et al.
Pageof 50

Showing results (481-490 of 499) with videos related to

Sort By:
Pageof 50
Regulatory Peptides|November 5, 1998
NPY receptor subtypes involved in the contraction of the proximal colon of the ratM Félétou, M Rodriguez, P Beauverger, et al.
Frontiers in Oncology|August 1, 2020
High Expression of FAP in Colorectal Cancer Is Associated With Angiogenesis and Immunoregulation ProcessesMairene Coto-Llerena, Caner Ercan, Venkatesh Kancherla, et al.
Pancreas|September 14, 2017
Efficacy of Peptide Receptor Radionuclide Therapy in a United States-Based Cohort of Metastatic Neuroendocrine Tumor Patients: Single-Institution Retrospective AnalysisBryson W Katona, Giorgio A Roccaro, Michael C Soulen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 11, 2025
Targeted β<sup>-</sup>-Particle Plus Conversion and Auger-Electron Therapy with <sup>161</sup>Tb-Labeled Somatostatin Receptor Antagonist DOTA-LM3: A Phase 0 StudyJulia G Fricke, Frida Westerbergh, Lisa McDougall, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 5, 2024
First-in-human administration of [<sup>161</sup>Tb]Tb-SibuDAB and comparative dosimetry with standard [<sup>177</sup>Lu]Lu-PSMA-I&T as part of the PROGNOSTICS phase Ia studyAlin Chirindel, Guillaume P Nicolas, Frida Westerbergh, et al.
The Journal of Clinical Endocrinology and Metabolism|August 11, 2021
Metastatic Medullary Thyroid Cancer: The Role of 68Gallium-DOTA-Somatostatin Analogue PET/CT and Peptide Receptor Radionuclide TherapyAimee R Hayes, Alexander Crawford, Khulood Al Riyami, et al.
Nature Communications|June 24, 2017
January 2016 extensive summer melt in West Antarctica favoured by strong El NiñoJulien P Nicolas, Andrew M Vogelmann, Ryan C Scott, et al.
Scientific Reports|May 19, 2022
Adaptation of the gut pathobiont Enterococcus faecalis to deoxycholate and taurocholate bile acidsF Repoila, F Le Bohec, C Guérin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 26, 2024
Dosimetry and pharmacokinetics of [<sup>177</sup>Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumoursSeval Beykan Schürrle, Uta Eberlein, Catherine Ansquer, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2001
Fit genotypes and escape variants of subgroup III Neisseria meningitidis during three pandemics of epidemic meningitisP Zhu, A van der Ende, D Falush, et al.
Pageof 50